Studies have shown that GSDMD was notably upregulated in osteosarcoma compared to normal skeletal tissue as well as associated with drug resistance and prognosis for patients with osteosarcoma (Lin R. et al., 2020). This evidence concerns the gene GSDMD and osteosarcoma.